University Of Washington

A quarter of patients with unresectable or metastatic angiosarcoma responded to a combination of ipilimumab and nivolumab, according to results of an analysis presented at the virtual Society for Immunotherapy of Cancer Annual Meeting.

Use of two IV antipseudomonal antibiotics was not associated with improvement in clinical outcomes compared with one IV and one inhaled antibiotic in young patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection.

A universal prevention program effectively reduced suicidal ideation and depression symptoms among a general Air Force population, according to results of a cluster randomized clinical trial published in JAMA Network Open.

Novel therapies are providing hope for more targeted therapy options in managing the myriad manifestations of psoriatic arthritis, according to a presenter at the 2020 Congress of Clinical Rheumatology-West.

Strong data for two interleukin-17 inhibitors have given a lift to clinicians treating the spondyloarthropathies, according to a presenter at the 2020 Congress of Clinical Rheumatology-West.

In a single-center experience, no patients hospitalized with COVID-19 who developed cardiac arrest survived to discharge after receiving CPR, researchers found.

A group of novel agents could change the way providers care for women experiencing moderate or severe vasomotor symptoms.

An IV injection of BIVV001 induced high sustained factor VIII activity levels among men with severe hemophilia A, according to results of a phase 1/phase 2 open-label trial published in The New England Journal of Medicine.

Chimeric antigen receptor T-cell therapy administration cost nearly $33,000 more at academic inpatient hospitals than nonacademic specialty oncology networks, according to study results published in JAMA Network Open.

Mary-Claire King, PhD, will receive the William L. McGuire Memorial Lecture Award at this year’s San Antonio Breast Cancer Symposium, which will be held Dec. 8-12.